Nat commun:突破:无痛皮肤贴针一周血糖正常,糖尿病患者告别药物和胰岛素

2017-12-27 Lily 来宝网

研究人员设计了一种生物化学配方的可溶解微针贴片,用于治疗2型糖尿病。补片中矿化化合物的生化公式响应血液化学自动管理葡萄糖。在对老鼠进行的一项概念研究中,研究人员发现,这些化学物质在血液中相互作用,一次可以调节血糖数天。

【无疼痛皮肤贴片对治疗2型糖尿病的血糖水平有反应】研究人员设计了一种生物化学配方的可溶解微针贴片,用于治疗2型糖尿病。补片中矿化化合物的生化公式响应血液化学自动管理葡萄糖。在对老鼠进行的一项概念研究中,研究人员发现,这些化学物质在血液中相互作用,一次可以调节血糖数天。

对数百万名2型糖尿病患者来说,持续警惕他们血液中的糖或葡萄糖含量是健康的关键。吃饭前手指刺痛测量血糖,注射胰岛素虽然不舒服但是确是必要的方法。

美国国立卫生研究院的国家生物医学成像和生物工程研究所(NIBIB)的研究人员设计了一种创新的矿化化合物生化配方,这种化合物可以在血液中相互作用,一天一天地调节血糖。在一项对小鼠进行的概念验证研究中,研究人员表明,生物化学配方的可溶解微针贴片能够对血液化学反应,自动管理葡萄糖。

研究人员表示:“这种实验方法可以利用2型糖尿病患者仍能产生一些胰岛素这一事实,每周一次的微针贴片应用程序也不会像常规那样需要频繁的血液测试,减少糖尿病患者的痛苦。”

胰岛素是一种在胰腺中分泌的激素,分泌到血液中以调节葡萄糖的摄入。它需要将葡萄糖从血液中转移到细胞中,在那里糖可以转化为能量或储存起来。1型糖尿病,通常是儿童和年轻人,他们的身体根本不制造胰岛素。2型糖尿病,出现在所有年龄段,但更常见的是成年人,身体制造或使用胰岛素的能力逐渐削弱。如果不加以治疗,糖尿病会导致全身血管和神经损伤,对眼睛、脚、肾脏和心脏造成损害。

所有类型糖尿病的全球发病率约为2亿8500万人,其中90%人患有2型糖尿病。许多人需要胰岛素治疗,通常是皮下注射,根据血液中自然生成的胰岛素的不足量来计算。胰岛素治疗在所有病例中没有得到很好的治疗。

研究人员正在研究对2型糖尿病使用无痛皮肤贴片的血糖水平的替代疗法。在2017年11月24日发表在《自然通讯》网上的一项研究中,研究小组将这种疗法应用于小鼠身上,以证明其潜在的有效性。实验贴片的基础是褐藻酸盐,一种类似褐藻的天然物质。它以混合药物的形式注入微针,藻酸盐是一种柔韧的材料,但是却能够戳到真皮,它不是一种常用的针头材料,在这种情况下似乎非常有效。

研究团队将海藻酸钠与公式生化颗粒相结合,刺激人体自身胰岛素的生产,使血糖浓度达到正常。这个补丁的响应传递系统可以满足身体几天的需要。

研究人员表示:“糖尿病是一种非常严重的疾病,影响着很多人,我们一直都在寻找一种长效配方。”没有疼痛的皮肤贴剂对管理2型糖尿病的血糖水平是一个重大突破。

研究人员的公式将两药物化合物,Exendin-4和葡萄糖氧化酶制成一个补丁。这两种化合物与血液化学反应触发胰岛素分泌。每一个都与磷酸盐矿物颗粒相匹配,使其稳定。当糖浓度升高时,酸性会减弱与药物的结合。Exendin-4与身体产生的基因分子相似,虽然它比自然产生的分子弱,但是持久的效果非常不错。然而,当吸收过多时会引起恶心。控制如何快速吸收也是非常重要的,研究人员结合将磷酸钙矿物颗粒与Exendin-4相结合,稳定到另一个化学反应的发生。这种化学反应是由葡萄糖酸氧化酶中的第二种药物化合物引起的,这种酶存在于磷酸铜的矿物缓冲液中。

研究人员解释说,当血糖升高超出一个精确的点的时候,它引发的反应与磷酸铜和葡萄糖氧化酶产生轻微的酸度,使磷酸钙释放一些Exendin-4。血糖水平上升引发Exendin-4的释放;但exendin-4得到胰岛素流动降低血糖水平,这会减慢和停止释放Exendin-4。这就是为什么我们称之为反应灵敏,大多数当前的方法都包括常量释放。我们的方法在需要的时候产生一个快速释放的波,然后在葡萄糖水平稳定的时候减慢甚至停止释放。

研究人员证明,一个半英寸见方的贴片含有足够的药物来控制老鼠体内的血糖水平一周。作为二型糖尿病患者可以使用的一种应用方法,研究小组需要进行测试,用含有更多治疗成分的贴剂来治疗较大的动物。除了它的尺寸外,贴片还需要在人体皮肤上进行修改,可能需要更长的针头。

研究人员表示:“我们需要扩大贴片的大小,优化针的长度、形状和形态。此外,修补程序需要与日常生活相适应,例如允许淋浴或出汗。

原始出处:

Wei Chen, Rui Tian, Can Xu, Bryant C. Yung,et al. Microneedle-array patches loaded with dual mineralized protein/peptide particles for type 2 diabetes therapy. Nature Communications, 2017; 8 (1) DOI: 10.1038/s41467-017-01764-1.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1882734, encodeId=fa021882e3471, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Feb 16 23:55:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087244, encodeId=8b5f208e244e7, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Jun 05 06:55:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749889, encodeId=40c21e4988988, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sat Jun 16 06:55:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273689, encodeId=53f52e368920, content=学习了不少事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4BGdu4COj6QWFqgMd3xnWDdgLZKUGI32veZvO2qFAQvpYr1eMbUOTqMvlZWc3MsugtFMHzxDwial/0, createdBy=88731939304, createdName=圣艮山, createdTime=Sat Dec 30 01:24:15 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474386, encodeId=b4cc14e43868f, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Dec 29 02:55:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272917, encodeId=20202e2917ca, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Dec 27 13:29:15 CST 2017, time=2017-12-27, status=1, ipAttribution=)]
    2018-02-16 liye789132251
  2. [GetPortalCommentsPageByObjectIdResponse(id=1882734, encodeId=fa021882e3471, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Feb 16 23:55:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087244, encodeId=8b5f208e244e7, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Jun 05 06:55:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749889, encodeId=40c21e4988988, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sat Jun 16 06:55:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273689, encodeId=53f52e368920, content=学习了不少事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4BGdu4COj6QWFqgMd3xnWDdgLZKUGI32veZvO2qFAQvpYr1eMbUOTqMvlZWc3MsugtFMHzxDwial/0, createdBy=88731939304, createdName=圣艮山, createdTime=Sat Dec 30 01:24:15 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474386, encodeId=b4cc14e43868f, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Dec 29 02:55:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272917, encodeId=20202e2917ca, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Dec 27 13:29:15 CST 2017, time=2017-12-27, status=1, ipAttribution=)]
    2018-06-05 liuli5079
  3. [GetPortalCommentsPageByObjectIdResponse(id=1882734, encodeId=fa021882e3471, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Feb 16 23:55:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087244, encodeId=8b5f208e244e7, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Jun 05 06:55:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749889, encodeId=40c21e4988988, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sat Jun 16 06:55:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273689, encodeId=53f52e368920, content=学习了不少事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4BGdu4COj6QWFqgMd3xnWDdgLZKUGI32veZvO2qFAQvpYr1eMbUOTqMvlZWc3MsugtFMHzxDwial/0, createdBy=88731939304, createdName=圣艮山, createdTime=Sat Dec 30 01:24:15 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474386, encodeId=b4cc14e43868f, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Dec 29 02:55:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272917, encodeId=20202e2917ca, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Dec 27 13:29:15 CST 2017, time=2017-12-27, status=1, ipAttribution=)]
    2018-06-16 baoya
  4. [GetPortalCommentsPageByObjectIdResponse(id=1882734, encodeId=fa021882e3471, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Feb 16 23:55:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087244, encodeId=8b5f208e244e7, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Jun 05 06:55:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749889, encodeId=40c21e4988988, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sat Jun 16 06:55:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273689, encodeId=53f52e368920, content=学习了不少事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4BGdu4COj6QWFqgMd3xnWDdgLZKUGI32veZvO2qFAQvpYr1eMbUOTqMvlZWc3MsugtFMHzxDwial/0, createdBy=88731939304, createdName=圣艮山, createdTime=Sat Dec 30 01:24:15 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474386, encodeId=b4cc14e43868f, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Dec 29 02:55:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272917, encodeId=20202e2917ca, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Dec 27 13:29:15 CST 2017, time=2017-12-27, status=1, ipAttribution=)]
    2017-12-30 圣艮山

    学习了不少事情

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1882734, encodeId=fa021882e3471, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Feb 16 23:55:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087244, encodeId=8b5f208e244e7, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Jun 05 06:55:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749889, encodeId=40c21e4988988, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sat Jun 16 06:55:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273689, encodeId=53f52e368920, content=学习了不少事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4BGdu4COj6QWFqgMd3xnWDdgLZKUGI32veZvO2qFAQvpYr1eMbUOTqMvlZWc3MsugtFMHzxDwial/0, createdBy=88731939304, createdName=圣艮山, createdTime=Sat Dec 30 01:24:15 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474386, encodeId=b4cc14e43868f, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Dec 29 02:55:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272917, encodeId=20202e2917ca, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Dec 27 13:29:15 CST 2017, time=2017-12-27, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1882734, encodeId=fa021882e3471, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Fri Feb 16 23:55:00 CST 2018, time=2018-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2087244, encodeId=8b5f208e244e7, content=<a href='/topic/show?id=490750196b' target=_blank style='color:#2F92EE;'>#COMMUN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5019, encryptionId=490750196b, topicName=COMMUN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7931272, createdName=liuli5079, createdTime=Tue Jun 05 06:55:00 CST 2018, time=2018-06-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1749889, encodeId=40c21e4988988, content=<a href='/topic/show?id=be7c8385345' target=_blank style='color:#2F92EE;'>#胰岛#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83853, encryptionId=be7c8385345, topicName=胰岛)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a7a536274692, createdName=baoya, createdTime=Sat Jun 16 06:55:00 CST 2018, time=2018-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=273689, encodeId=53f52e368920, content=学习了不少事情, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/oLAjfB7s1ib06iaV3D9Tg5K4BGdu4COj6QWFqgMd3xnWDdgLZKUGI32veZvO2qFAQvpYr1eMbUOTqMvlZWc3MsugtFMHzxDwial/0, createdBy=88731939304, createdName=圣艮山, createdTime=Sat Dec 30 01:24:15 CST 2017, time=2017-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1474386, encodeId=b4cc14e43868f, content=<a href='/topic/show?id=935fe6718e3' target=_blank style='color:#2F92EE;'>#糖尿病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=20, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=76718, encryptionId=935fe6718e3, topicName=糖尿病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a38f7243741, createdName=xue8604, createdTime=Fri Dec 29 02:55:00 CST 2017, time=2017-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=272917, encodeId=20202e2917ca, content=谢谢分享.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo6Nx0VGA4QMDzOP8oAgnV4h51EjSfehJ9QxyiaSmw8PB56BhY8KXFSxHCibXrzcy4abrzSibXQPxJ9kzrLcJyhhB8a/0, createdBy=1d3b1672603, createdName=明月清辉, createdTime=Wed Dec 27 13:29:15 CST 2017, time=2017-12-27, status=1, ipAttribution=)]
    2017-12-27 明月清辉

    谢谢分享.学习了

    0

相关资讯

中华内分泌代谢杂志:中国糖尿病合并血脂异常专家共识:他汀增加糖尿病风险,但获益已得到充分肯定

2型糖尿病患者合并血脂异常,可进一步增加大血管和微血管并发症的风险。近期,中华医学会内分泌学分会根据中国患者的疾病特点,修订了2011年版的《中国2型糖尿病合并血脂异常防治专家共识》。

Eur Radiol:糖尿病的患者既有肝硬化又有脂肪肝,那心脏会不会受牵连呢?

本研究旨在验证是否II型糖尿病(DM)患者非酒精性脂肪肝(NAFLD)和肝硬化程度与冠心病(CHD)风险具有相关性,并将结果发表在Eur Radiol上。

如果您患有糖尿病,你应该知道2018年医疗标准!

每年,美国糖尿病协会都会发布新的糖尿病患者指南。以下是关于最新的规则如何影响你和你的家人的内容。

Lancet Diabetes Endo:阿卡波糖对冠心病合并糖耐量受损患者心血管和糖尿病结局的影响

2017年发表于《Lancet Diabetes Endocrinol》上的一项随机、双盲、安慰剂对照试验,考察了阿卡波糖对冠心病合并糖耐量受损患者心血管和糖尿病结局的影响。

JACC:CVD一级预防:可通过管理糖尿病、高脂血症和高血压而实现?

因为高血压、糖尿病、高脂血症等问题,血管会经历“沉积-钙化-狭窄-破裂/闭塞”这样一个病变过程后,最终走向的结局就是我们所熟悉的心脑血管急性事件。2017年发表在《J Am Coll Cardiol》上的一项摘要,对冠心病的一级预防可通过管理糖尿病、高脂血症和高血压而实现进行了描述。

JAHA:胰岛素和二甲双胍对糖尿病心肌损伤和应激的影响!

治疗12周后,甘精胰岛素与心肌应激标志物NT-proBNP显著增加20.7%相关,而判断心肌损伤的指标hsTnT没有观察到变化。这些变化与血糖控制的实质性改善无关。